Submission of Annual Secretarial Compliance Report for the year ended March 31, 2025, pursuant to the Regulation 24A of SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted its Annual Secretarial Compliance Report (ASCR) to BSE for the financial year ended March 31, 2025, as mandated under Regulation 24A of SEBI LODR Regulations. The report was issued by Practicing Company Secretary Mr. Kashinath Sahu after reviewing the company's filings, website, and compliance records. The report confirms the company complied with all applicable SEBI regulations, including the Listing Regulations, Insider Trading rules, and Disclosure Requirements. All 13 specific areas checked — such as Secretarial Standards, director disqualification, related party transactions, insider trading, website disclosures, and document preservation — were marked as compliant (Yes) or Not Applicable. No deviations, penalties, or actions by SEBI or stock exchanges were reported during the review period.
This is a routine annual compliance filing with no negative findings, which is positive but expected. No material impact on the stock price is expected; it simply confirms the company is in good regulatory standing.